All living cells are metabolically active.
They produce heat. We measure it.
Simplicity. Specificity. Sensitivity.
And Amazing Speed.
We are Masters of Biocalorimetry.
Strategic R&D collaboration
Accelerating Therapy ACCESS
Sterility testing is the most time-consuming step in releasing cell therapies. Current methods can take 7–14 days, delaying access to critical treatments.
This collaboration aims to deliver a validated, GMP-compliant test that cuts release time to under 3 days, improving manufacturing efficiency with faster access for patients.
IF THERE IS LIFE, THERE IS HEAT
Biocalorimetry
Biocalorimetry measures life through heat. It is versatile and powerful in its simplicity. By detecting metabolic heat from living organisms with high sensitivity, it enables faster results and deeper insights across a wide range of applications and sample types.
We are Masters of the Craft.
Get in touch to explore how biocalorimetry can support your microbial and cell research and testing. .
faster release times for cell & gene therapies
Rapid sterility testing
Our biocalorimetry system has the capability to transform rapid sterility testing for advanced therapies. With its seamless, easy workflow, it delivers the fastest detection of living microorganisms. This enables release testing in three days or less. We help developers and clinical labs make significant savings in cost, cut vein-to-vein times and improve patient access.
Contact us to join the innovators shaping the future of rapid microbial testing.
Insights & Resources
Knowledge
Hub
Stay up to date with the latest developments in biocalorimetry and its applications. In our Knowledge Hub you will find news, publications, and insights from Symcel and our partners.
Subscribe to our newsletter to receive the latest updates directly in your inbox.
Stay up-to-date
Advancing 3-day sterility testing for cell and gene therapies
Learn about the latest developments in rapid sterility testing for cell and gene therapies.
16 SEPTEMBER 2025
Symcel enters into R&D collaboration with Johnson & Johnson to advance rapid sterility testing in cell & gene therapies
28 May 2025
New investment boosts Symcel’s development and rollout of rapid sterility testing solutions for advanced therapies
4th March 2025